Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
10/2014
10/02/2014US20140294958 Lubricious coatings
10/02/2014US20140294956 Gastric retentive extended release pharmaceutical compositions
10/02/2014US20140294955 Misuse preventative, controlled release formulation
10/02/2014US20140294954 Misuse preventative, controlled release formulation
10/02/2014US20140294953 Abuse-Resistant Formulations
10/02/2014US20140294952 Dissolvable medication admisistration bag and method of using the same
10/02/2014US20140294950 Methods of treating obesity in responder and non-responder populations
10/02/2014US20140294947 Tamper resistant immediate release formulations
10/02/2014US20140294945 Methods and devices for forming treatment agent carriers
10/02/2014US20140294944 Microencapsulation of oxygen liberating reactants
10/02/2014US20140294937 Lipid compositions for nucleic acid delivery
10/02/2014US20140294932 Temperature sensitive liposome including cationic lipid and use thereof
10/02/2014US20140294929 Compositions for delivery of cargo such as drugs proteins and/or genetic materials
10/02/2014US20140294927 Synthetic nanostructures including nucleic acids and/or other entities
10/02/2014US20140294924 Regeneration of Pancreatic Islets and Reversal of Diabetes by Islet Transcription Factor Genes Delivered In Vivo
10/02/2014US20140294923 Acth for treatment of migraine headache
10/02/2014US20140294920 Transdermal propranolol patch for treatment of malignant melanoma
10/02/2014US20140294919 Vaccines
10/02/2014US20140294917 Thermoset and thermoplastic fibers and preparation thereof by uv curing
10/02/2014US20140294916 Methylphenidate Extended Release Chewable Tablet
10/02/2014US20140294915 Chewing Gum With Tomatidine
10/02/2014US20140294914 Intraocular encapsulation of oxygenic bacteria
10/02/2014US20140294913 Biodegradable bone fillers, membranes and scaffolds containing composite particles
10/02/2014US20140294909 Nanocomposites of gold and polymers
10/02/2014US20140294908 Supporting material for cell sheet
10/02/2014US20140294904 Water-in-oil emulsions and methods for their preparation
10/02/2014US20140294750 Aqueous pharmaceutical compositions containing borate-polyol complexes
10/02/2014US20140290654 Inhalation Apparatus
10/02/2014DE102013009744A1 Fusionsmischung zur lipidhaltigen Membranmodifikation einer beliebigen Lipidmembran, einer Zellmembran, einem Bestandteil einer Zellmembran oder einer von den übrigen Zell- Bestandteilen getrennten Zellmembran in vivo oder in vitro Fusion mixture for lipid-containing membrane of any modification of the lipid membrane, a cell membrane, a component of a cell membrane or a position separated from the other cell components in vivo or in vitro cell membrane
10/02/2014DE102013005154A1 Verfahren zum Einbau von lysosomalen Transmembranproteinen in zelluläre Membranen A method for incorporation of transmembrane proteins into cellular lysosomal membranes
10/01/2014EP2783703A1 Semifluorocarbon compound containing contrast agent
10/01/2014EP2783702A1 Water insoluble gel composition and method for preparing same
10/01/2014EP2783695A1 Physiological supplement or medicament for ophthalmic use containing L-carnitine or alkanoyl L-carnitines in combination with eledoisin
10/01/2014EP2783688A1 Pharmaceutical tablets of crystalline type ii aripiprazole
10/01/2014EP2783687A1 Composition for inhibition of cathepsin K
10/01/2014EP2783682A1 Pharmaceutical composition comprising pimobendan
10/01/2014EP2783681A1 Extended release formulations of metformin
10/01/2014EP2783680A1 Controlled-release formulations comprising metformin and gliclazide
10/01/2014EP2783679A1 Drug carrier with chelating composite micell and use thereof
10/01/2014EP2782584A2 Natural combination hormone replacement formulations and therapies
10/01/2014EP2782561A1 Controlled release particles comprising dimethyl fumarate
10/01/2014EP2782560A1 Imatinib solid dosage forms reconstituted just before use
10/01/2014EP2782559A1 Pharmaceutical composition comprising myo-inositol and d-chiro-inositol
10/01/2014EP2782558A1 Immediate release abuse deterrent tablet
10/01/2014EP2782557A1 Pharmaceutical formulations
10/01/2014EP2782556A1 A method of producing a delivery device
10/01/2014EP2782555A2 Platelet lysate gel
09/2014
09/30/2014US8849441 Systems, devices, and methods for making or administering frozen particles
09/30/2014US8846901 Sulfoalkyl ether cyclodextrin compositions and methods of preparation thereof
09/30/2014US8846771 Compositions and methods of delivery of pharmacological agents
09/30/2014US8846770 Controlled release aural pressure modulator compositions and methods for the treatment of OTIC disorders
09/30/2014US8846769 Composition made of polyalkoxylated derivatives of trimethylolpropane and fatty alcohols, method for preparing said composition, and use thereof as a reverser in self-reversible reverse latexes
09/30/2014US8846744 Pharmaceutical compositions of co-crystals of tramadol and coxibs
09/30/2014US8846740 Biotherapeutics for the treatment of infectious diseases
09/30/2014US8846725 Highly penetrating compositions and methods for treating pathogen-induced disordered tissues
09/30/2014US8846694 Pyrrolidone derivatives for use as MetAP-2 inhibitors
09/30/2014US8846680 Pharmaceutical composition comprising pimobendan
09/30/2014US8846679 Pharmaceutical composition comprising pimobendan
09/30/2014US8846664 Pyrazinopyrazines and derivatives as kinase inhibitors
09/30/2014US8846650 Method of treating middle ear infections
09/30/2014US8846649 Natural combination hormone replacement formulations and therapies
09/30/2014US8846648 Natural combination hormone replacement formulations and therapies
09/30/2014US8846646 Topical treatment of skin infection
09/30/2014US8846644 Phosphate-containing nanoparticle delivery vehicle
09/30/2014US8846641 Stabilized ophthalmic galactomannan formulations
09/30/2014US8846633 Method for inhibiting cancer stem cell like properties and chemoradioresistant properties of cancer or tumor cells with microRNA145
09/30/2014US8846628 Oral formulations of cytidine analogs and methods of use thereof
09/30/2014US8846623 Cancer-targeting peptides and uses thereof in cancer treatment and diagnosis
09/30/2014US8846622 Targeted delivery of botulinum toxin to the sphenopalatine ganglion
09/30/2014US8846611 Skin conditions using human growth hormone
09/30/2014US8846607 Particles for treatment of pulmonary infection
09/30/2014US8846605 Formulations and methods of use for alpha connexin C-terminal (ACT) peptides
09/30/2014US8846604 Lipid compositions with high DHA content
09/30/2014US8846106 Enhanced transport using membrane disruptive agents
09/30/2014US8846105 Dry powder fibrin sealant
09/30/2014US8846104 Pharmaceutical compositions for the deterrence and/or prevention of abuse
09/30/2014US8846103 Exogenously triggered controlled release materials and uses thereof
09/30/2014US8846102 Non-viral compositions and methods for transfecting gut cells in vivo
09/30/2014US8846101 Film-coated and/or granulated calcium-containing compounds and use thereof in pharmaceutical compositions
09/30/2014US8846100 Controlled dose drug delivery system
09/30/2014US8846099 Parenteral composition comprising microspheres with a diameter between 10 and 20 microns
09/30/2014US8846098 Artificial cell constructs for cellular manipulation
09/30/2014US8846097 Process for producing organic-modified inorganic fine particles
09/30/2014US8846096 Nanoparticles and methods of use
09/30/2014US8846095 Dextran-based polymer tissue adhesive for medical use
09/30/2014US8846094 Peripherally administered viscous formulations
09/30/2014US8846093 Adhesive mixture for transdermal delivery of highly plasticizing drugs
09/30/2014US8846092 Gum resin as a carrier for topical application of pharmacologically active agents
09/30/2014US8846091 Matrix for sustained, invariant and independent release of active compounds
09/30/2014US8846090 Matrix for sustained, invariant and independent release of active compounds
09/30/2014US8846089 Sugar-coated preparation and production method for the same
09/30/2014US8846088 Melt granulation of a composition containing a calcium-containing compound
09/30/2014US8846087 Formulation for providing an enteric coating material
09/30/2014US8846086 Tamper resistant dosage forms
09/30/2014US8846085 Method for production of directly compressible ibuprofen formulations
09/30/2014US8846084 Controlled release compositions containing zolpidem
09/30/2014US8846083 Method for the diffusion of molecules which are insoluble in an aqueous medium and composition using said method
09/30/2014US8846082 Probiotic and preservative uses of oil-emulsified probiotic encapsulations
09/30/2014US8846081 Liposome compositions and methods of use thereof
09/30/2014US8846080 Vaccine
1 ... 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 ... 2991